Global Veterinary CRO And CDMO Market 2026–2030: Forecast Insights for Business Planning

January 28, 2026January 28, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the heat stress prevention products market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Veterinary CRO And CDMO Market?

The veterinary cro and cdmo market has experienced significant expansion in recent years. It is projected to expand from $7.53 billion in 2025 to $8.2 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.9%. The market’s historical growth can be attributed to several factors, including the constrained in-house R&D capabilities of veterinary companies, an increasing companion animal population, a rise in the prevalence of animal diseases, the early adoption of CDM/O services within developed regions, and the demand for innovative veterinary biologics and drugs.

The veterinary CRO and CDMO market is projected to experience substantial expansion in the coming years, anticipated to reach a valuation of $11.81 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.6%. Key factors driving this growth during the forecast period include a rising demand for contract research and manufacturing services, progress in veterinary drug development technology, the expansion of veterinary biologics and pharmaceuticals, an increase in global regulatory compliance mandates, and the growing application of precision medicine in animal care. Significant trends expected in the forecast period encompass an uptick in the outsourcing of veterinary drug development, the broadening of preclinical and clinical trial offerings, an increasing need for regulatory consulting, the implementation of sophisticated analytical and formulation services, and a heightened emphasis on post-marketing surveillance and pharmacovigilance.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

Which Drivers Are Supporting The Rise Of The Veterinary CRO And CDMO Market?

The projected increase in pet ownership is anticipated to fuel the expansion of the veterinary CRO and CDMO market. Pet ownership refers to the status of a person or household primarily responsible for the welfare, care, and management of a domesticated animal, embodying a lasting legal and ethical dedication. This rise in pet ownership stems from a growing understanding of the emotional and health advantages pets offer, as individuals increasingly seek companionship, stress reduction, and overall improved well-being through caring for animals. The veterinary CRO and CDMO market plays a crucial role in supporting this trend, as the growing population of pets necessitates increased demand for the creation and production of veterinary pharmaceuticals, vaccines, and therapies to safeguard pet health and safety. For instance, data from the American Pet Products Association, a US-based non-profit organization, indicates that by March 2025, ninety-four (94) million U.S. households will own at least one pet, an increase from eighty-two (82) million in 2023. Consequently, the surge in pet ownership is expected to propel the veterinary CRO and CDMO market forward.

What Segments Are Identified Within The Structure Of The Veterinary CRO And CDMO Market?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, Market Approval And Post-marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By Market Approval And Post-marketing: Regulatory Submissions, Pharmacovigilance, Post-marketing Surveillance

What Trends Are Projected To Support The Growth Of The Veterinary CRO And CDMO Market?

Key players within the veterinary CRO and CDMO market are concentrating on developing innovative services, such as integrated multi-site CDMO networks that incorporate advanced sterile manufacturing, lyophilization, and specialized dosage capabilities. This strategic focus aims to streamline drug development processes and accelerate compliant routes to commercialization. Integrated multi-site CDMO networks are unified platforms combining multiple production locations and expert technologies, including sterile multidose systems, lyophilization, and flexible packaging, all managed under harmonized operational and quality frameworks to deliver comprehensive pharmaceutical development and manufacturing services. For instance, in April 2025, Meribel Pharma Solutions, a UK-based full-service CDMO offering drug development, formulation, analytical services, sterile and semi-solid manufacturing, and packaging solutions, launched its operations. This launch included a network of 13 facilities across France, Spain, and Sweden, designed to support products from early development stages through to commercial-scale production, establishing centers of excellence in oral solid dose, preservative-free multidose, and lyophilization technologies for both human and veterinary health products.

Which Key Players Are Driving Competition In The Veterinary CRO And CDMO Market?

Major companies operating in the veterinary cro and cdmo market are Eurofins Scientific SE, Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited, Aenova Group, Taconic Bioscience Inc., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Cebiphar, Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l., Syneos Health Inc., Pharmaceutical Product Development Inc., Inotiv Inc., Promega Corporation, Triveritas Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

Which Region Is Projected To Lead The Veterinary CRO And CDMO Market During The Forecast Period?

North America was the largest region in the veterinary CRO and CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary cro and cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Veterinary CRO And CDMO Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12080&type=smp

Browse Through More Reports Similar to the Global Veterinary CRO And CDMO Market 2026, By The Business Research Company

Biologics Cdmo Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-cdmo-global-market-report

Healthcare Cro Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-cro-services-global-market-report

Preclinical Cro Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795